C. Nerl

Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: Prognostic impact of clinical observations and laboratory findings at presentation

W. Siegert, C. Nerl, Alexander G Agthe et al. · Annals of Oncology · 1995 · 131 citations · Full text

Lymphoid Neoplasia, T-cell Lymphoma, Hematology +9

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

Martin C. Müller, Norbert Gattermann, Tanja Lahaye et al. · Leukemia · 2003 · 125 citations

Hematological Malignancy, First-line Therapy, Medicine +9

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV

Manuel Barreto Miranda, Michael Lauseker, M-P Kraus et al. · Leukemia · 2016 · 87 citations · Full text

Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea

Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann et al. · Leukemia · 2003 · 80 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Health Sciences +8

In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.

Dieter Kabelitz, Klaus Pfeffer, D von Steldern et al. · The Journal of Immunology · 1985 · 49 citations

Il 2, Lymphocyte Development, Immunology +17